Phase 2 Trial Archives - Wellness News 24

First Patient Treated in Phase 2 GvHD Trial

1 min read

First Patient Treated in Phase 2 GvHD Trial

Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, confirms that...

First patient treated in the second dose group in Annexin’s RVO study

Annexin Pharmaceuticals announces that all patients in the first dose group with the lowest dose have now...

Phase 2 Trial

First Patient Treated in Phase 2 GvHD Trial

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer

First patient treated in the second dose group in Annexin’s RVO study

You may have missed

Boston Scientific Launches AVVIGO™+ Multi-Modality Guidance System in India

KW Delhi-6 Mall Joined Hands with Yashoda Healthcare to Spread Awareness on Breast Cancer

India’s reputation as the “Pharmacy to the World” is Potentially Under Threat Substandard Imports of IPA add to the Quality Burden

Sculpt Clinics Introduces New Laser Hair Removal Technology